These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 26283663

  • 1. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.
    Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, Currier JS, Grinsztejn B, Lake JE.
    Nutr J; 2015 Aug 18; 14():81. PubMed ID: 26283663
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial.
    Sudfeld CR, Mugusi F, Aboud S, Nagu TJ, Wang M, Fawzi WW.
    Trials; 2017 Feb 10; 18(1):66. PubMed ID: 28183335
    [Abstract] [Full Text] [Related]

  • 3. Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial.
    Rovner AJ, Stallings VA, Rutstein R, Schall JI, Leonard MB, Zemel BS.
    Osteoporos Int; 2017 Jan 10; 28(1):201-209. PubMed ID: 27837268
    [Abstract] [Full Text] [Related]

  • 4. Cholecalciferol supplementation in HIV-infected youth with vitamin D insufficiency: effects on vitamin D status and T-cell phenotype: a randomized controlled trial.
    Giacomet V, Vigano A, Manfredini V, Cerini C, Bedogni G, Mora S, Borelli M, Trabattoni D, Zuccotti GV.
    HIV Clin Trials; 2013 Jan 10; 14(2):51-60. PubMed ID: 23611825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of high dose vitamin D3 therapy on serum vitamin D3 levels in vitamin D insufficient adults with cystic fibrosis.
    Regalado Lam Chew Tun R, Porhownik N, Taback S, Oleschuk C.
    Clin Nutr ESPEN; 2018 Feb 10; 23():84-88. PubMed ID: 29460819
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Hoffman RM, Lake JE, Wilhalme HM, Tseng CH, Currier JS.
    AIDS Res Hum Retroviruses; 2016 Mar 10; 32(3):247-54. PubMed ID: 26569649
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determination of optimal vitamin D3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach.
    Foissac F, Meyzer C, Frange P, Chappuy H, Benaboud S, Bouazza N, Friedlander G, Souberbielle JC, Urien S, Blanche S, Tréluyer JM.
    Br J Clin Pharmacol; 2014 Nov 10; 78(5):1113-21. PubMed ID: 24902982
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy.
    Cervero M, Agud JL, García-Lacalle C, Alcázar V, Torres R, Jusdado JJ, Moreno Guillén S.
    AIDS Res Hum Retroviruses; 2012 Sep 10; 28(9):963-71. PubMed ID: 22242918
    [Abstract] [Full Text] [Related]

  • 15. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
    Stubbs JR, Zhang S, Friedman PA, Nolin TD.
    Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1965-73. PubMed ID: 25183657
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D levels in Swiss breast cancer survivors.
    Baumann M, Dani SU, Dietrich D, Hochstrasser A, Klingbiel D, Mark MT, Riesen WF, Ruhstaller T, Templeton AJ, Thürlimann B.
    Swiss Med Wkly; 2018 Nov 07; 148():w14576. PubMed ID: 29376548
    [Abstract] [Full Text] [Related]

  • 17. Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.
    Muhihi A, Fawzi WW, Aboud S, Nagu TJ, Ulenga N, Wang M, Mugusi F, Sudfeld CR.
    J Nutr; 2022 Aug 09; 152(8):1983-1990. PubMed ID: 35460249
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy.
    Sudfeld CR, Wang M, Aboud S, Giovannucci EL, Mugusi FM, Fawzi WW.
    PLoS One; 2012 Aug 09; 7(6):e40036. PubMed ID: 22768212
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
    Simoneau T, Sawicki GS, Milliren CE, Feldman HA, Gordon CM.
    J Cyst Fibros; 2016 Mar 09; 15(2):234-41. PubMed ID: 26211605
    [Abstract] [Full Text] [Related]

  • 20. Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
    Wohl DA, Orkin C, Doroana M, Pilotto JH, Sungkanuparph S, Yeni P, Vanveggel S, Deckx H, Boven K.
    Antivir Ther; 2014 Mar 09; 19(2):191-200. PubMed ID: 24430534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.